SUBOXONE FILM 4/1 buprenorphine (as hydrochloride) 4 mg/naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet Australia - inglese - Department of Health (Therapeutic Goods Administration)

suboxone film 4/1 buprenorphine (as hydrochloride) 4 mg/naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet

indivior pty ltd - buprenorphine hydrochloride, quantity: 4.32 mg (equivalent: buprenorphine, qty 4 mg); naloxone hydrochloride dihydrate, quantity: 1.22 mg (equivalent: naloxone, qty 1 mg) - soluble film - excipient ingredients: acesulfame potassium; citric acid; maltitol solution; hypromellose; polyethylene oxide; sodium citrate; sunset yellow fcf; flavour; titanium dioxide; propylene glycol; purified water; industrial methylated spirit - treatment of opiate dependence within a framework of medical, social, and pyschological treatment.

BUPRADONE 8/2 buprenorphine (as hydrochloride) 8 mg and naloxone (as hydrochloride dihydrate) 2 mg sublingual tablet Australia - inglese - Department of Health (Therapeutic Goods Administration)

bupradone 8/2 buprenorphine (as hydrochloride) 8 mg and naloxone (as hydrochloride dihydrate) 2 mg sublingual tablet

indivior pty ltd - buprenorphine hydrochloride, quantity: 8.64 mg (equivalent: buprenorphine, qty 8 mg); naloxone hydrochloride dihydrate, quantity: 2.44 mg (equivalent: naloxone, qty 2 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; mannitol; povidone; citric acid; sodium citrate dihydrate; acesulfame potassium; magnesium stearate; flavour - for the treatment of opiate dependence within a framework of medical, social, and psycological treatment.

BUPRADONE 2/0.5 buprenorphine (as hydrochloride) 2 mg and naloxone (as hydrochloride dihydrate) 0.5 mg sublingual tablet Australia - inglese - Department of Health (Therapeutic Goods Administration)

bupradone 2/0.5 buprenorphine (as hydrochloride) 2 mg and naloxone (as hydrochloride dihydrate) 0.5 mg sublingual tablet

indivior pty ltd - buprenorphine hydrochloride, quantity: 2.16 mg (equivalent: buprenorphine, qty 2 mg); naloxone hydrochloride dihydrate, quantity: 0.61 mg (equivalent: naloxone, qty 0.5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; mannitol; povidone; citric acid; sodium citrate dihydrate; acesulfame potassium; magnesium stearate; flavour - for the treatment of opiate dependence within a framework of medical, social, and psychological treatment.

BUPRADEX buprenorphine 8mg (as hydrochloride) tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

bupradex buprenorphine 8mg (as hydrochloride) tablet blister pack

indivior pty ltd - buprenorphine hydrochloride, quantity: 8.64 mg (equivalent: buprenorphine, qty 8 mg) - tablet - excipient ingredients: lactose monohydrate; mannitol; maize starch; povidone; citric acid; sodium citrate dihydrate; magnesium stearate - treatment of opiate dependence, including maintenance and detoxification, within a framework of medical, social and psychological treatment.

BUPRADEX buprenorphine 2mg (as hydrochloride) tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

bupradex buprenorphine 2mg (as hydrochloride) tablet blister pack

indivior pty ltd - buprenorphine hydrochloride, quantity: 2.16 mg (equivalent: buprenorphine, qty 2 mg) - tablet - excipient ingredients: lactose monohydrate; mannitol; maize starch; povidone; citric acid; sodium citrate dihydrate; magnesium stearate - treatment of opiate dependence, including maintenance and detoxification, within a framework of medical, social and psychological treatment.

BUPRADEX buprenorphine 0.4mg (as hydrochloride) tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

bupradex buprenorphine 0.4mg (as hydrochloride) tablet blister pack

indivior pty ltd - buprenorphine hydrochloride, quantity: 0.43 mg (equivalent: buprenorphine, qty 0.4 mg) - tablet - excipient ingredients: lactose monohydrate; mannitol; maize starch; povidone; citric acid; sodium citrate dihydrate; magnesium stearate - treatment of opiate dependence, including maintenance and detoxification, within a framework of medical, social and psychological treatment.

SUBUTEX FDT buprenorphine 16 mg (as hydrochloride) tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

subutex fdt buprenorphine 16 mg (as hydrochloride) tablet blister pack

indivior pty ltd - buprenorphine hydrochloride, quantity: 17.28 mg (equivalent: buprenorphine, qty 16 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; citric acid; magnesium stearate; crospovidone; acesulfame potassium; flavour - for the treatment of opiate dependence, including maintenance and detoxification, within a framework of medical, social and psychological treatment.

SUBUTEX FDT buprenorphine 8 mg (as hydrochloride) tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

subutex fdt buprenorphine 8 mg (as hydrochloride) tablet blister pack

indivior pty ltd - buprenorphine hydrochloride, quantity: 8.64 mg (equivalent: buprenorphine, qty 8 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; citric acid; magnesium stearate; crospovidone; acesulfame potassium; flavour - for the treatment of opiate dependence, including maintenance and detoxification, within a framework of medical, social and psychological treatment.

SUBOXONE 8/2 sublingual tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

suboxone 8/2 sublingual tablet blister pack

indivior pty ltd - buprenorphine hydrochloride, quantity: 8.64 mg (equivalent: buprenorphine, qty 8 mg); naloxone hydrochloride dihydrate, quantity: 2.44 mg (equivalent: naloxone, qty 2 mg) - tablet - excipient ingredients: lactose monohydrate; sodium citrate dihydrate; maize starch; acesulfame potassium; mannitol; citric acid; magnesium stearate; povidone; flavour - for the treatment of opiate dependence within a framework of medical, social, and psycological treatment.

SUBOXONE 2/0.5 sublingual tablet blister pack Australia - inglese - Department of Health (Therapeutic Goods Administration)

suboxone 2/0.5 sublingual tablet blister pack

indivior pty ltd - naloxone hydrochloride dihydrate, quantity: 0.61 mg (equivalent: naloxone, qty 0.5 mg); buprenorphine hydrochloride, quantity: 2.16 mg (equivalent: buprenorphine, qty 2 mg) - tablet - excipient ingredients: citric acid; acesulfame potassium; magnesium stearate; mannitol; povidone; maize starch; lactose monohydrate; sodium citrate dihydrate; flavour - for the treatment of opiate dependence within a framework of medical, social, and psychological treatment.